,outcome,arm 1,arm 2
0,intervention,pioglitazone group,glimepiride group
0,"12 weeks of therapy, HbA ( 1c ) values","7.46 %, 8.66 %",7.77 %
0,"52 weeks, 12 weeks of therapy, HbA ( 1c ) values",NR,7.80 %
